Newsroom

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to three classes of notes issued by ACHD Trust 2026-DS1 (“ACHD 2026-DS1”), an ABS transaction collateralized by a pool of debt settlement (“DS”) fees associated with enrolled debts from a static pool of DS customers. ACHD 2026-DS1 will issue three classes of notes totaling $151.4 million. The transaction benefits from credit enhancement levels that are sufficient to withstand KBRA’s rating stresses. Credit enhancement is comprised of o...

MIAMI--(BUSINESS WIRE)--Lucky Strike Entertainment Corporation (NYSE: LUCK) announced today the promotion of Bobby Lavan to President and Chief Financial Officer....

RALEIGH, N.C.--(BUSINESS WIRE)--Opex Technologies (“Opex” or the “Company”), a leading Trusted Advisor for Technology Transformation Projects (TTP) and Strategic Leadership as a Service (SlaaS), today announced a strategic acquisition of Intellys Corporation (“Intellys”), a Dallas-based technology advisory firm specializing in multi-vendor support, carrier solutions, and managed IT services. The transaction marks a significant step toward building a national, scaled platform serving enterprise...

CHICAGO--(BUSINESS WIRE)--Coeur Mining, Inc. (“Coeur” or the “Company”) (NYSE, TSX: CDE) today announced that it will be added to the S&P MidCap 400 Index, effective prior to the open of trading on Monday, June 22, 2026. Coeur’s addition to the S&P MidCap 400 Index reflects the Company’s growth and transformation into the sector’s only all-North American senior precious metals producer and a leading global silver company following two recent successful acquisitions, and its commitment t...

RAHWAY, N.J. & FOSTER CITY, Calif.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Gilead Sciences, Inc. (Nasdaq: GILD) today announced the discontinuation of the Phase 3 KEYNOTE-D46/EVOKE-03 study investigating Gilead’s Trodelvy® (sacituzumab govitecan-hziy) in combination with KEYTRUDA® (pembrolizumab), Merck’s anti-PD-1 therapy, compared to KEYTRUDA monotherapy in certain patients with previously untreated metastatic non-small cell lung cancer,...

NEW YORK--(BUSINESS WIRE)--ANV Group Holdings Ltd. (“ANV” or “the Company”), a global insurance intermediary platform, has successfully completed the acquisition of Associated Specialty Insurance Agency LLC (“ASIA”), a wholesale commercial insurance agency headquartered in Springfield, Pennsylvania, focused primarily on workers’ compensation insurance. Founded in 1994, ASIA is a specialist wholesale agency with over 30 years of experience placing workers’ compensation coverage for brokers and a...

NEW YORK--(BUSINESS WIRE)--KKR Income Opportunities Fund (the “Fund”) (NYSE: KIO) today announced its monthly distributions of $0.1215 per common share, payable on the dates below. Based on the Fund’s current share price of $11.26 per share (as of market close on June 5, 2026), the distributions represent an annualized distribution rate of 12.95% (calculated by annualizing the distribution amount and dividing it by the current price). The monthly distribution schedule is as follows for the mont...

ST. LOUIS--(BUSINESS WIRE)--Geneoscopy, Inc., a life sciences company focused on developing diagnostic tests for the advancement of gastrointestinal health, today announced that the Centers for Medicare & Medicaid Services (CMS) has approved coverage for FDA-approved ColoSense, a stool-based colorectal (CRC) screening test, within the National Coverage Determination (NCD) for colorectal cancer screening tests. Coverage for ColoSense provides Medicare's approximately 65 million eligible bene...

NEW YORK--(BUSINESS WIRE)--KBRA is pleased to announce the assignment of preliminary ratings to 13 classes of BMO 2026-5C15, a $626.1 million CMBS conduit transaction collateralized by 25 commercial mortgage loans secured by 124 properties. The collateral properties are located throughout 44 MSAs, of which the three largest are New York (32.6% of pool balance), Philadelphia (6.9%), and Reno, NV (5.9%). The pool’s three largest property type exposures are multifamily (34.9%), industrial (31.7%),...

MEMPHIS, Tenn.--(BUSINESS WIRE)--The Board of Directors of FedEx Corp. (NYSE: FDX) today approved a 5% increase in the annual dividend rate on FedEx Corp. common stock, after a one-time annual rate adjustment in connection with the spin-off of FedEx Freight. The dividend increase and spin-off adjustment result in an annualized dividend rate of $4.88 for the transition period covering June 1, 2026 through Dec. 31, 2026. Consistent with this update, the Board today also declared a quarterly cash...